Private Equity
Moll Ramos, the mid-market firm’s third add-on for its plastic molding platform, allows the firm to expand its company into Mexico.
2 min read · 05 January 2013
Réal Desrochers has ended his 11-year reign as the director of alternative investments at the US' second largest public pension, leaving veteran portfolio managers Margot Wirth and Seth Hall as interim co-directors. Desrochers did not disclose future professional plans in a farewell email sent to friends and colleagues.
4 min read · 05 January 2013
The California pension is set to create a $6bn securities portfolio targeting distressed sellers that will cut across all asset classes. To make room for the portfolio, the pension is shifting its asset class allocations, including increasing allocations to private equity and real estate.
2 min read · 05 January 2013
The $28bn national oil fund has cancelled commitments to funds including Alinda and Pathway Capital as it tries to re-focus on ‘core’ asset classes amid continuing losses.
2 min read · 05 January 2013
Portfolio companies of several private equity firms have had to recall products after salmonella contamination forced the nationwide recall of 1,800 products this month, costing companies millions and driving Emigrant Capital-backed Forward Foods into bankruptcy.
2 min read · 05 January 2013
The British Private Equity and Venture Capital Association is the latest to jump on the green investing bandwagon, having formed a group to promote cleantech investment. Last week KKR touted its green accomplishments at the portfolio company level.
2 min read · 05 January 2013
The New York-based turnaround firm has made three acquisitions as part of the platform, including the purchase of Labatt USA for an undisclosed amount.
2 min read · 05 January 2013
The US mega-firm, which has recently pledged to adopt socially responsible investment strategies, says three of its portfolio companies have saved more than $16m through green policies, with other portfolios set to follow.
2 min read · 05 January 2013
As the global economy sinks, interest in distressed and turnaround investments has grown.
1 min read · 05 January 2013
The $700m sale of medical device company CoreValve vindicates the venture firm’s strategy, proving wrong pundits who thought the firm the ‘last of the early stage Mohicans’, according to managing partner Antoine Papiernik. The deal is expected to generate more than 10x for the firm’s investors.
2 min read · 05 January 2013
